Holen Sie sich die Stockscreener-App
1.48
0.68%
0.01
Handel nachbörslich:
1.49
0.01
+0.68%
Schlusskurs vom Vortag:
$1.47
Offen:
$1.48
24-Stunden-Volumen:
179.88K
Relative Volume:
0.77
Marktkapitalisierung:
$137.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.60M
KGV:
49.33
EPS:
0.03
Netto-Cashflow:
$-62.91M
1W Leistung:
+1.37%
1M Leistung:
-6.92%
6M Leistung:
-32.42%
1J Leistung:
-15.43%
1-Tages-Spanne:
$1.47
$1.53
1-Wochen-Bereich:
$1.43
$1.53
52-Wochen-Spanne:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Vergleichen Sie CGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.48 | 137.50M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-26 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-05-13 | Eingeleitet | Stifel | Buy |
| 2020-05-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-22 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Eingeleitet | Oppenheimer | Outperform |
| 2016-02-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-23 | Fortgesetzt | Jefferies | Buy |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-02-07 | Eingeleitet | MLV & Co | Buy |
| 2009-12-28 | Bestätigt | Cantor Fitzgerald | Buy |
| 2009-07-29 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Compugen Ltd Aktie (CGEN) Neueste Nachrichten
Historical volatility pattern of Compugen Ltd. visualizedPortfolio Growth Summary & Real-Time Market Trend Scan - Newser
Pattern recognition hints at Compugen Ltd. upsideAnalyst Upgrade & Capital Efficient Trading Techniques - Newser
What data driven models say about Compugen Ltd.’s futureQuarterly Market Review & Accurate Buy Signal Notifications - Newser
Should you wait for a breakout in Compugen Ltd.Price Action & AI Forecasted Entry/Exit Points - Newser
Can Compugen Ltd. hit a new high this monthJuly 2025 PostEarnings & Precise Buy Zone Identification - Newser
Compugen Ltd. stock retracement – recovery analysis [July 2025 EndofMonth]Free Reliable Trade Execution Plans - Newser
Real time scanner hits for Compugen Ltd. explainedFree AI Driven Stock Trend Forecast - Newser
Is Compugen Ltd. showing insider buyingLow Drawdown High Profit Portfolio - newsyoung.net
Can Compugen Ltd. recover in the next quarterReal-Time AI Sentiment and Price Forecast - Newser
How to read the order book for Compugen Ltd.Free Growth Based Investment Plan Guidance - Newser
Real time pattern detection on Compugen Ltd. stockSmart Risk Entry Zone Technical Analysis - Newser
Leerink Partnrs Predicts Increased Earnings for Compugen - Defense World
Is Compugen Ltd. forming a reversal patternStrategy Chart for Real-Time Trade Flow - Newser
Intrinsic Value of Compugen Ltd. Stock: Is It Undervalued or OvervaluedIn-Depth Stock Trading Volume Analysis - Newser
Compugen Ltd. stock prediction for this weekMarket Correction Proof Stock Screening Analysis - Newser
Compugen signals leadership transition and advances COM701 ovarian cancer trial with interim data targeted for 2026 - MSN
Need To Know: Analysts Just Made A Substantial Cut To Their Compugen Ltd. (NASDAQ:CGEN) Estimates - Yahoo Finance
Using portfolio simulators with Compugen Ltd. includedBuy Point Strategy with Profit Protection - Newser
How Compugen Ltd. stock performs during market volatilityPredictive Short-Term Market Reversal Alerts - Newser
Compugen (NASDAQ:CGEN) Downgraded by Wall Street Zen to Sell - Defense World
Using Bollinger Bands to evaluate Compugen Ltd.Free Capital Protection Trading Strategies - Newser
Using data tools to time your Compugen Ltd. exitForecast Model for Intraday Buy Signals - Newser
Understanding Compugen Ltd.’s price movementFree Weekly Hot Picks With Buy Confidence - Newser
How Efficient Is Compugen Ltd. at Controlling Operating CostsMarket Timing Strategy with Technical Filters - Newser
Compugen Reports Q2 2025 Earnings with Strategic Progress Amid Financial Challenges - AInvest
Compugen Reports Q2 Earnings: Revenue Down, Net Loss Up, and Ovarian Cancer Competition Rises Amid Strong Partnerships and Cash Reserves - AInvest
Compugen (CGEN) Gets a Buy from Leerink Partners - The Globe and Mail
Compugen Ltd. (NASDAQ:CGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Compugen's COM701 Shifts Focus to Targeting PSOC Patients, With Multiple Catalysts Ahead - AInvest
Compugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC Patients - Seeking Alpha
Will Compugen Ltd. Stock Benefit from AI and Green Energy TrendsRSI and MACD Signal Summary with Trends - Newser
Compugen Ltd. stock momentum explainedFree ROI Boosting Trade Opportunity Calendar - Newser
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment? - TipRanks
Compugen price target raised to $13 from $10 at Leerink - TipRanks
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials - The Globe and Mail
Compugen stock price target raised to $13 from $10 at Leerink Partners - Investing.com Australia
Is Compugen Ltd. stock entering bullish territoryReliable Setup Screener with Low Risk - Newser
Compugen Reports Q2 2025 Results and Strategic Progress - TipRanks
Advanced analytics toolkit walkthrough for Compugen Ltd.Trading Watchlist with Real Time Filters - Newser
Compugen Ltd. recovery potential after sell offInvestment Position Summary with Timeframe Forecast - Newser
Compugen: Q2 Earnings Snapshot - The Washington Post
Compugen Ltd. shares fall 1.37% intraday after Q2 2025 earnings call. - AInvest
Compugen Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com
Compugen Reports Q2 Loss, Misses Revenue Estimates - AInvest
Compugen Announces 2025 Annual General Meeting: Election of Directors and Financial Oversight on Agenda - AInvest
Compugen Ltd. Announces 2025 Annual General Meeting Details - TipRanks
Finanzdaten der Compugen Ltd-Aktie (CGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):